Evidence map›Paper›PMID 25324420›Full record

ArticleThe Journal of antimicrobial chemotherapy2015

Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability.

Anne Makena, Jürgen Brem, Inga Pfeffer, Rebecca E J Geffen, Sarah E Wilkins, Hanna Tarhonskaya, Emily Flashman, Lynette M Phee, David W Wareham, Christopher J Schofield

Open access · hybridAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Prevalence of New Delhi Metallo-β-lactamase (blaMolecular biology reports · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants.Antimicrobial agents and chemotherapy · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Metallo-ß-lactamases: a review.Molecular biology reports · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Anne MakenaDepartment of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK.
Jürgen BremDepartment of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK.
Inga PfefferDepartment of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK.
Rebecca E J GeffenDepartment of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK.
Sarah E WilkinsDepartment of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK.
Hanna TarhonskayaDepartment of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK.
Emily FlashmanDepartment of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK.
Lynette M PheeAntimicrobial Research Group, Queen Mary University London, London E1 2AT, UK.
David W WarehamAntimicrobial Research Group, Queen Mary University London, London E1 2AT, UK.
Christopher J SchofieldDepartment of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK christopher.schofield@chem.ox.ac.uk.
University of Oxford · GBQueen Mary University of London · GB

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council G1100135
6 · The paper itself

Abstract

objectivesMetallo-β-lactamase (MBL)-based resistance is a threat to the use of most β-lactam antibiotics. Multiple variants of the New Delhi MBL (NDM) have recently been reported. Previous reports indicate that the substitutions affect NDM activity despite being located outside the active site. This study compares the biochemical properties of seven clinically reported NDM variants.

methodsNDM variants were generated by site-directed mutagenesis; recombinant proteins were purified to near homogeneity. Thermal stability and secondary structures of the variants were investigated using differential scanning fluorimetry and circular dichroism; kinetic parameters and MIC values were investigated for representative carbapenem, cephalosporin and penicillin substrates.

resultsThe substitutions did not affect the overall folds of the NDM variants, within limits of detection; however, differences in thermal stabilities were observed. NDM-8 was the most stable variant with a melting temperature of 72°C compared with 60°C for NDM-1. In contrast to some previous studies, kcat/KM values were similar for carbapenem and penicillin substrates for NDM variants, but differences in kinetics were observed for cephalosporin substrates. Apparent substrate inhibition was observed with nitrocefin for variants containing the M154L substitution. In all cases, cefoxitin and ceftazidime were poorly hydrolysed with kcat/KM values <1 s(-1) μM(-1).

conclusionsThese results do not define major differences in the catalytic efficiencies of the studied NDM variants and carbapenem or penicillin substrates. Differences in the kinetics of cephalosporin hydrolysis were observed. The results do reveal that the clinically observed substitutions can make substantial differences in thermodynamic stability, suggesting that this may be a factor in MBL evolution.

Indexed as

Genetic VariationAnti-Bacterial AgentsBacteriabeta-LactamasesCloning, MolecularEscherichia coliHumansHydrolysisKineticsMass SpectrometryMicrobial Sensitivity TestsModels, MolecularMutagenesis, Site-DirectedPlasmidsProtein ConformationProtein StabilityAnti-Bacterial Agentsbeta-lactamase NDM-1beta-LactamasesRecombinant Proteinsantibiotic resistancecarbapenemasescephalosporinsthermal stabilityβ-lactams

Identifiers

PMID25324420
PMCPMC4291237
OpenAlexW2135864659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.